`
Thursday, 20 July 2017

Contract Manufacturing News

  • ScinoPharm to invest in oncological products plant

    Contract Manufacturing |  News | By BioSpectrum Bureau | 0 Comment | 29 Jun, 2012

    Singapore: ScinoPharm will invest NT$1.13 billion (approximately $37.6 million) in the construction of a high potency cytotoxic injectable plant suitable for production of oncological injec...Read more

Survey Box

Is value- based patient healthcare system more effective in Asian countries?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls